======= HEYL ======= == Gene Information == * **Official Symbol**: HEYL * **Official Name**: hes related family bHLH transcription factor with YRPW motif like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26508|26508]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQ87|Q9NQ87]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HEYL&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HEYL|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609034|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Downstream effector of Notch signaling which may be required for cardiovascular development (By similarity). Transcriptional repressor which binds preferentially to the canonical E box sequence 5'-CACGTG-3' (By similarity). Represses transcription by the cardiac transcriptional activators GATA4 and GATA6. {ECO:0000250, ECO:0000269|PubMed:15485867}. |HLH| |Hairy orange| |AF-1 domain binding| |proximal tubule development| |Notch signaling involved in heart development| |epithelial to mesenchymal transition involved in endocardial cushion formation| |negative regulation of androgen receptor signaling pathway| |pulmonary valve morphogenesis| |positive regulation of transcription of Notch receptor target| |endocardial cushion formation| |pulmonary valve development| |cell surface receptor signaling pathway involved in heart development| |atrioventricular valve morphogenesis| |regulation of androgen receptor signaling pathway| |atrioventricular valve development| |aortic valve morphogenesis| |cardiac epithelial to mesenchymal transition| |aortic valve development| |endocardial cushion morphogenesis| |negative regulation of intracellular steroid hormone receptor signaling pathway| |semi-lunar valve development| |ventricular septum morphogenesis| |endocardial cushion development| |skeletal muscle cell differentiation| |mesenchyme morphogenesis| |glomerulus development| |heart valve morphogenesis| |heart valve development| |epithelial to mesenchymal transition| |ventricular septum development| |cardiac ventricle morphogenesis| |outflow tract morphogenesis| |cardiac septum morphogenesis| |regulation of intracellular steroid hormone receptor signaling pathway| |nephron tubule development| |renal tubule development| |mesenchymal cell development| |nephron epithelium development| |cellular response to BMP stimulus| |response to BMP| |cardiac septum development| |skeletal muscle tissue development| |nephron development| |Notch signaling pathway| |cardiac chamber morphogenesis| |cardiac ventricle development| |kidney epithelium development| |skeletal muscle organ development| |mesenchymal cell differentiation| |negative regulation of DNA-binding transcription factor activity| |cardiac chamber development| |anterior/posterior pattern specification| |mesenchyme development| |transcription corepressor activity| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |heart morphogenesis| |kidney development| |renal system development| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |RNA polymerase II regulatory region sequence-specific DNA binding| |urogenital system development| |regionalization| |transcription factor binding| |positive regulation of neuron differentiation| |regulation of DNA-binding transcription factor activity| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |positive regulation of neurogenesis| |muscle structure development| |protein heterodimerization activity| |cellular response to growth factor stimulus| |RNA polymerase II proximal promoter sequence-specific DNA binding| |heart development| |response to growth factor| |positive regulation of nervous system development| |positive regulation of cell development| |tissue morphogenesis| |regulation of neuron differentiation| |DNA-binding transcription factor activity| |regulation of neurogenesis| |tube development| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |protein homodimerization activity| |anatomical structure formation involved in morphogenesis| |regulation of nervous system development| |regulation of cell development| |animal organ morphogenesis| |positive regulation of cell differentiation| |epithelium development| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of response to stimulus| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17575 * **Expression level (log2 read counts)**: -5.28 {{:chemogenomics:nalm6 dist.png?nolink |}}